Politico May 1, 2024
Erin Schumaker, Daniel Payne, Carmen Paun and Ruth Reader

Social workers are prepping for the psychedelic revolution.

The Food and Drug Administration has set a target date of Aug. 11 for a decision on the first drug application for talk therapy combined with MDMA, commonly called ecstasy, as a treatment for post-traumatic stress disorder. Should the FDA approve Lykos Therapeutics’ application, universities that train social workers, psychologists and psychiatrists want to be ready.

The Columbia University School of Social Work is rolling out a 25-person psychedelic-assisted training program this fall, which includes 120 hours of classroom coursework and 600 hours of clinical experience in a ketamine clinic.

Unlike independent training programs, which can run thousands of dollars per course, Columbia isn’t charging its masters’ students extra, said Heidi Allen,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Mental Health, Patient / Consumer, Provider
The silent struggles of men’s mental health and suicide prevention
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
The Future of Behavioral Health Delivery
Fixing the Growing Payer-Provider Divide in Behavioral Health
Workers Feel “Stuck,” Under-Insured, Financially Stressed, and Neglecting Mental Health

Share This Article